Celltrion Sets Up JV With Nan Fung To Sell Biosimilars In China

 
• By Dave Wallace

Celltrion is pushing into biosimilar market opportunities in China by setting up a joint venture with local player Nan Fung Group. Vcell Healthcare is aiming to market three of Celltrion’s biosimilars as well as exploring setting up a manufacturing plant in China.

China - South Korea
Korea’s Celltrion has linked up with China’s Nan Fung Group • Source: Shutterstock

More from Deals

More from Business